Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201106427 Principal Investigator: Bartlett, Nancy
Title: A phase 2 study of brentuximab vedotin in relapsed or refractory CD30-positive non-Hodgkin lymphoma (NHL)
Phase: II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to test if brentuximab vedotin (SGN-35) has an effect on cancer in patients with non Hodgkin lymphoma. The side effects of SGN-35 in patients with non Hodgkin lymphoma will also be studied.
 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)